What is the first-line oral agent for most adults with type 2 diabetes and its primary mechanism?

• A. Metformin; Suppression of Hepatic Gluconeogenesis and Increased Insulin Sensitivity
• B. Sulfonylurea; Increased Insulin Secretion
• C. DPP-4 Inhibitor; Increased Incretin Levels
• D. SGLT2 Inhibitor; Increased Glucose Excretion

Answer: (A)

Metformin is the first-line oral agent for most adults with type 2 diabetes, and its main action is to reduce hepatic glucose production while improving insulin sensitivity in liver and muscle. By activating pathways that lower the liver’s output of glucose and by helping tissues use glucose more effectively, metformin lowers both fasting and postprandial glucose without driving up insulin levels, which keeps the risk of hypoglycemia low. This combination of effective glycemic control, favorable safety profile, and potential cardiovascular/weight benefits makes it the preferred starting medication.

The other options represent different drug classes with distinct mechanisms. Increasing insulin secretion from the pancreas can lower glucose but comes with hypoglycemia risk and weight gain. Elevating incretin levels boosts insulin release and suppresses glucagon, offering moderate glucose lowering. Promoting glucose excretion in the kidneys reduces blood glucose but is not typically started as the first-line agent due to other considerations such as cost and tolerability.